KwaZulu-Natal to launch its first dedicated XDR-TB facility to combat drug-resistant tuberculosis

Tailored TB treatment based on disease severity may improve patient outcomes

A new article published in Nature offers a promising path toward a shorter, more effective treatment for tuberculosis (TB), a bacterial disease that affects millions worldwide.

KwaZulu-Natal to launch its first dedicated XDR-TB facility to combat drug-resistant tuberculosis

Why don’t we have a good tuberculosis vaccine?  - The Oxford Scientist

Despite being discovered more than a century ago, tuberculosis still lacks an effective vaccine leading to millions of deaths. Photo credits: CDC via Unsplash Tuberculosis (TB) is thought to be the world’s leading cause of death from a single infectious agent, killing 1.25 million people in 2023. Most TB cases in humans are caused by the bacterium Mycobacterium tuberculosis and can be treated with antibiotics. Nevertheless, a good TB vaccine wou…